OTC
Print adverts’ prescribing info could be axed
March 3, 2014Medical Communications MHRA, OTC, medicines, prescribing
The UK drugs regulator is proposing new rules that could see pharma update safety information for their medicines online, whilst …
Pfizer expands in Poland
December 4, 2013Sales and Marketing OTC, Pfizer, Poland, polocard, zf polpharma
Pfizer has bought the rights to one of Poland’s biggest OTC brands in a move which sees the US group …
Pharmstandard buys Singapore API firm to guarantee supply
August 16, 2013Manufacturing and Production OTC, Pharmstandard, bever
Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …
J&J says revived OTC brands are ‘winning the hearts of consumers’
July 19, 2013Manufacturing and Production, Sales and Marketing Control, FDA, GDP, J&J, JJ, OTC
Johnson & Johnson doesn’t usually provide specific financials for its over-the-counter pharmaceuticals business, but did so for the first time …
Novartis’ Nebraska OTC plant still troubles company
February 11, 2013Manufacturing and Production Novartis, OTC
Novartis has been forced to recall various over-the-counter (OTC) medicines made at its plant in Lincoln, Nebraska, after discovering failures …
Lundbeck sells $100m portfolio
January 22, 2013Sales and Marketing Lundbeck, OTC, Panhematin, Recordati
Italian pharma group Recordati has paid $80 million to Lundbeck for a portfolio of products primarily aimed at the US …
Pfizer pays $250m for OTC Nexium rights
August 14, 2012Sales and Marketing AstraZeneca, EMA, FDA, Nexium, OTC, Pfizer
Pfizer will pay $250 million to AstraZeneca in order to gain the rights to sell an over-the-counter form of the …
J&J expects consent decree to extend through ‘most of 2013’
July 30, 2012Manufacturing and Production FDA, J&J, JJ, McNeil, OTC, recall
Johnson & Johnson has said it expects the production capacity issues affecting two plants covered by a consent decree with …
GSK sells off OTC products
March 16, 2012Sales and Marketing GSK, OTC, Omega Pharma, Zantac
GlaxoSmithKline has shed more of its non-core consumer health OTC products in a £391 million sale, including a German manufacturing …
Prescription drugs could become OTC under FDA plans
March 12, 2012Sales and Marketing COPD, FDA, OTC, prescribing
The FDA is considering new plans to make drugs for chronic conditions available over-the-counter. These drugs could include medicines for …
Novartis appoints Brian McNamara to division head of OTC business
March 1, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brian McNamara, Novartis, OTC
Novartis has appointed Brian McNamara to the position of division head of its OTC (Over-the-Counter) business with immediate effect. McNamara …
Novartis recalls products as GMP issues close OTC facility
January 9, 2012Manufacturing and Production FDA, Novartis, OTC
Novartis has revealed that it is temporarily shutting down a manufacturing facility in Nebraska, US, and recalling four products as …
GSK sells off over-the-counter brands
December 22, 2011Sales and Marketing GSK, OTC
GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash. Flagged up …
Merck pulls out of J&J consumer venture
September 29, 2011Sales and Marketing J&J, JJ, Merc & Co, OTC
Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …
GlaxoSmithKline to drop Alli and other OTC products
April 15, 2011Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb
GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
